Kristin Abate
Chief Accounting Officer · 1 filing · Latest: May 13, 2026
Karyopharm Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
KPTI | Kristin Abate | Chief Accounting Officer | May 14, 2026 | Sale | $9.50 | 53 | $504 | 23,801 | |
KPTI | Kristin Abate | Chief Accounting Officer | May 13, 2026 | Grant/Award | $0.00 | 121 | — | 23,854 | |